Search results
Results from the Tech24 Deals Content Network
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
Barely a month ago, investors of Amarin (AMRN) were left dismayed following a lost patent trial against two generic drug makers seeking to sell their own versions of Amarin’s high triglycerides ...
One week ago, Stifel analyst Derek Archila reiterated his "buy" rating on anti-cholesterol drugmaker Amarin (AMRN). He did this partly because he liked how Amarin's Q2 earnings report showed sales ...
amarincorp .com. Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. [ 1] The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
Share repurchase, also known as share buyback or stock buyback, is the reacquisition by a company of its own shares. [ 1] It represents an alternate and more flexible way (relative to dividends) of returning money to shareholders. [ 2] When used in coordination with increased corporate leverage, buybacks can increase share prices.
Pershing Square Tontine Holdings was a blank check company formed by Bill Ackman that went public on July 22, 2020, at a value of $4 billion and traded under the ticker symbol PSTH.U before the split of its warrants and shares. [39]
Today, Amarin (AMRN) investors are scratching their heads as to why the stock tumbled following the announcement that the FDA has approved the label extension of the company’s fish oil drug ...
Berkshire also received warrants to purchase 43.5 million shares with a strike price of $115 per share, which were exercisable at any time for a five-year term. [132] Goldman maintained the right to purchase back the preferred stock and in March 2011 exercised this right paying $5.5 billion to Berkshire (the preferred stock could only be ...